APOLLO HOSPITALS ENTER. L vs SURAKSHA DIAGNOSTIC LTD

A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and SURAKSHA DIAGNOSTIC LTD (SURAKSHA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, APOLLO HOSPITALS ENTER. L leads APOLLOHOSP vs SURAKSHA on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability22
  • Growth02
  • Size & financial health40
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

64.66
P/E ratio
55.05
12.55
P/B ratio
5.73
0.23%
Dividend yield
0.15%
₹135.04
EPS
₹6.18

Profitability

Even

How efficiently each company turns capital and sales into profit. Higher is better.

22.10%
Return on equity
14.10%
18.00%
Return on capital
17.00%
15.00%
EBITDA margin
31.00%
7.94%
Net margin
10.00%

Growth

SURAKSHA takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
17.73%
33.39%
Profit CAGR (3Y)
72.88%

Size & financial health

APOLLOHOSP takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.26L Cr
Market cap
₹1,772 Cr
₹25,228 Cr
Revenue
₹310 Cr
₹2,003 Cr
Net profit
₹31 Cr
0.32
Debt / equity
0.51
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 76.2% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
SURAKSHA DIAGNOSTIC LTD
  • + ["Company has delivered good profit growth of 31.7% CAGR over last 5 years"]
  • ["Stock is trading at 7.24 times its book value"]
APOLLO HOSPITALS ENTER. L full analysis SURAKSHA DIAGNOSTIC LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.